Method Peptides · Research compound
$15 flat rate on orders under $200.
Tracking is provided when the order ships.
Research reference
Product specifications, research context, and handling information.
PT-141, also known as bremelanotide, is a synthetic cyclic peptide studied for its interaction with melanocortin receptors, central nervous system signaling, receptor activation, and behavioral-response research pathways.
In research settings, PT-141 is commonly evaluated for its influence on melanocortin receptor activity, neural communication pathways, centrally mediated response models, receptor selectivity, and peptide structure-activity relationships.
PT-141 is studied as a melanocortin receptor agonist capable of interacting with multiple melanocortin receptor subtypes. Research models evaluate how this receptor activation may influence central neural signaling, behavioral responses, and communication between melanocortin-regulated pathways.
Unlike compounds that act primarily through peripheral vascular pathways, PT-141 is of research interest for its centrally mediated mechanism and its interaction with melanocortin signaling systems within the nervous system.
PT-141 has gained interest in melanocortin and neurological research because its activity is associated with centrally mediated receptor pathways rather than relying exclusively on peripheral signaling mechanisms.
It is also examined in research involving receptor pharmacology, behavioral-response signaling, neural communication, melanocortin receptor subtype activity, and the biological properties of cyclic peptide analogs.
This product is intended strictly for laboratory and research purposes. Not for human consumption, medical use, diagnostic use, or therapeutic use.
